Logo

Ulrich Krauss

Sep 16, 2016

Analytik Jena has appointed current Chief Marketing and Sales Officer Ulrich Krauss as CEO, effective Oct. 1. Krauss will succeed founder Klaus Berka who will stay on to oversee the company's research and development efforts. Krauss has held various international management positions at the Carl Zeiss Group, most recently as the CEO of Carl Zeiss Vision. He has also served on the executive board of Carl Zeiss Meditec for over nine years.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.